Pharmacoepidemiology Expert Witnesses
Pharmacoepidemiology expert witnesses and consultants listed here may be able to form expert opinions, draft expert witness reports, provide expert witness testimony at deposition and/or trial as or serve as consulting (non-testifying) experts on pharmacoepidemiology. The pharmacoepidemiology expert witness listings on this page are typically from fields/areas of expertise such as: Occupational Medicine, Pharmaceutical Research, Preventive Medicine, and Public Health.
Remington Nevin, MD, MPH, DrPH
Physician Epidemiologist - Former Military
Remington Nevin Medicolegal, PLLC
Port Huron, Michigan
Preventive Medicine, Occupational Medicine
-
public health, travel medicine, epidemiology, pharmacoepidemiology, drug safety, preventive medicine, occupational medicine, malaria, antimalarials, mefloquine, chloroquine, hydroxychloroquine, primaquine, tafenoquine, quinoline, quinine
Remington Nevin, MD, MPH, DrPH, a former U.S. Army medical officer, is a physician epidemiologist and experienced expert witness in the fields of occupational medicine, preventive medicine, epidemiology, and public health. Trained in epidemiology at Johns Hopkins, board certified in Public Health and General Preventive Medicine and in Occupational Medicine by the American Board of Preventive Medicine, and licensed to practice medicine in four states (MD, MI, NY, VT), Dr. Nevin is an active researcher, primarily in the adverse effects of quinoline antimalarials. Dr. Nevin taught for 10 years at Johns Hopkins and has over 80 scientific publications with over 1,500 citations, primarily on topics related to antimalarial adverse effects, malaria, military mental health, and military-civilian health policy.
Eileen E. Ming, MPH, ScD, FISPE
Epi Excellence LLC
Garnet Valley, Pennsylvania
Public Health, Pharmaceutical Research
-
epidemiology, pharmacoepidemiology, outcomes research, observational research, real world evidence
Eileen E. Ming, MPH, ScD, FISPE, is an epidemiologist, pharmacoepidemiologist, outcomes researcher, and leader in the pharmaceutical industry. She served as an outcomes researcher at Merck, an epidemiologist at AstraZeneca, and the head of global epidemiology and pharmacoepidemiology at Shire Pharmaceuticals. Dr. Ming founded Epi Excellence, an epidemiology consulting practice, in 2014. She has worked across a variety of therapeutic areas, from pre-clinical through post-marketing phases, providing epidemiologic strategic and tactical expertise to commercial, clinical development, market access, medical affairs, regulatory, and pharmacovigilance activities.
Dr. Ming is an Adjunct Scholar of the Center for Clinical Epidemiology and Biostatistics, and an Adjunct Investigator of the Center for Pharmacoepidemiology Research and Training, at the Perelman School of Medicine at the University of Pennsylvania. She is a Fellow of the International Society for Pharmacoepidemiology. Dr. Ming r...
